论文部分内容阅读
目的 :研究分析丙型肝炎患者的临床检验方法与效果。方法 :选取我院2015年6月~2016年10月接受治疗的40例丙型肝炎患者为主要研究对象,采用试验研究方式,常规采取静脉血,离心采取血清,作为备用。参与此次研究的全部患者都行酶联免疫法与胶体金法的双向检查,研究分析试验方法的有效性。结果 :针对行酶联免疫法的患者,显示阳性的有2例,阳性率达5.0%;针对行胶体金法的患者,显示阳性的有3例,阳性率达7.5%,差异不具备统计学意义。由此可知,两种方法均可用于丙型肝炎的临床检验,且均具备有效性。结论 :应用胶体金法进行丙型肝炎的临床检验,操作简答方便,整体时间段,观察直观,并且无须另外配备特殊的设备,可靠性高。此外,还可进行单份测定,在急诊与临床的优势十分明显。
Objective: To study and analyze the clinical test methods and effects of hepatitis C patients. Methods: Forty patients with hepatitis C treated in our hospital from June 2015 to October 2016 were selected as the main study subjects. The venous blood was taken routinely and the serum was taken by centrifugation as a backup. All patients involved in this study are bi-directional enzyme-linked immunosorbent assay and colloidal gold to study and analyze the effectiveness of the test method. Results: Two patients were positive for enzyme-linked immunosorbent assay (ELISA), the positive rate was 5.0%. Three patients with colloidal gold were positive, the positive rate was 7.5%, the difference was not statistically significant significance. This shows that both methods can be used for clinical testing of hepatitis C, and are effective. Conclusion: The colloidal gold method for clinical testing of hepatitis C, easy to operate simple, the overall time, intuitive observation, and without additional equipment with special equipment, high reliability. In addition, single-dose assays are available and the benefits are clear in both emergency and clinical settings.